Position in VRTX
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$10,928,615,912
+$1,444,322,907 QoQ
Shares Held
24,105,823
-0.5% QoQ
Ownership
9.50%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.0012196223294263797.ToString("F0")%
Shared 6.729768156017739.ToString("F0")%
None 93.26901222165283.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. VRTX ranks #1 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $10,928,615,912 | 24,105,823 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,484,293,005 | 24,216,865 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $10,673,125,518 | 23,973,777 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $11,388,984,673 | 23,491,161 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $9,366,112,576 | 23,258,288 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $10,771,082,579 | 23,159,634 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,769,086,201 | 22,975,521 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,479,011,286 | 22,676,518 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $9,066,396,216 | 22,282,180 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $7,644,492,213 | 21,983,356 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $7,705,406,928 | 21,895,959 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,883,067,108 | 21,846,152 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $6,222,314,645 | 21,546,903 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $6,118,656,563 | 21,132,336 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,872,073,868 | 20,838,475 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,342,961,725 | 20,473,471 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,426,222,900 | 20,155,842 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,708,099,717 | 20,442,691 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,082,849,822 | 20,249,218 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,387,132,132 | 20,415,711 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,829,147,034 | 20,433,050 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,630,140,756 | 20,689,919 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,059,686,206 | 20,873,157 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,903,897,032 | 20,608,939 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||